Published in Laryngoscope on April 01, 2006
The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res (2009) 1.31
Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy. PLoS One (2012) 1.20
Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. J Virol (2014) 1.01
Epstein-barr virus sequence variation-biology and disease. Pathogens (2012) 0.95
Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia. World J Surg Oncol (2008) 0.85
Serum CXCL9 levels are associated with tumor progression and treatment outcome in patients with nasopharyngeal carcinoma. PLoS One (2013) 0.76
The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies. Syst Rev (2015) 0.75
From Conventional to Next Generation Sequencing of Epstein-Barr Virus Genomes. Viruses (2016) 0.75
Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology (2006) 2.49
The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis (2002) 1.90
Pathological analysis of congenital cervical cysts in children: 20 years of experience at Chang Gung Memorial Hospital. Chang Gung Med J (2003) 1.61
Risk stratification of patients with oral cavity squamous cell carcinoma and contralateral neck recurrence following radical surgery. Ann Surg Oncol (2008) 1.58
Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet (2009) 1.53
Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol (2002) 1.53
Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol Cell Proteomics (2010) 1.52
Treatment of squamous cell carcinoma of the retromolar trigone. Laryngoscope (2006) 1.51
Complications of mandibulotomy: midline versus paramidline. Otolaryngol Head Neck Surg (2003) 1.44
Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma. Biomed J (2013) 1.43
Phyllodes tumor in survivors of childhood osteosarcoma: a single institution's experience. J Pediatr Hematol Oncol (2014) 1.41
Hyperacute rejection from a donor who died of carbamate intoxication--a case report. Am J Emerg Med (2011) 1.39
High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet (2009) 1.39
Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res (2006) 1.38
Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol (2007) 1.37
JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism. Proc Natl Acad Sci U S A (2013) 1.34
Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics (2005) 1.32
Cul4A is an oncogene in malignant pleural mesothelioma. J Cell Mol Med (2011) 1.21
Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma. Proteomics (2006) 1.20
Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. J Clin Invest (2013) 1.19
Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome. Int J Cancer (2011) 1.19
Papillary thyroid carcinomas with lung metastases. Thyroid (2004) 1.18
Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications. Cancer (2008) 1.16
A type II first branchial cleft cyst masquerading as an infected parotid Warthin's tumor. Chang Gung Med J (2006) 1.15
Curcumin prevents methylglyoxal-induced oxidative stress and apoptosis in mouse embryonic stem cells and blastocysts. J Cell Physiol (2005) 1.15
Mitochondrion-targeted photosensitizer enhances the photodynamic effect-induced mitochondrial dysfunction and apoptosis. Ann N Y Acad Sci (2005) 1.15
Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma. Histol Histopathol (2009) 1.15
Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma. J Nucl Med (2012) 1.14
Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma. EMBO Mol Med (2012) 1.14
Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients. J Proteome Res (2012) 1.14
Adrenal cystic lesions: a clinicopathological analysis of 25 cases with proposed histogenesis and review of the literature. Endocr Pathol (2008) 1.14
Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer. Mol Cell Proteomics (2012) 1.14
Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One (2012) 1.14
Survival of second and multiple primary tumors in patients with oral cavity squamous cell carcinoma in the betel quid chewing area. Oral Oncol (2006) 1.12
Extrathyroid carcinoma showing thymus-like differentiation (CASTLE) tumor--a new case report and review of literature. Head Neck (2005) 1.11
Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro Oncol (2010) 1.11
Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology. J Proteome Res (2010) 1.10
Retroperitoneal teratomas in infancy and childhood. Pediatr Surg Int (2005) 1.09
Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics (2008) 1.09
Regarding "Transvaginal single-port natural orifice transluminal endoscopic surgery". J Minim Invasive Gynecol (2013) 1.09
Intra-abdominal cystic lymphangiomas in infancy and childhood. Chang Gung Med J (2004) 1.08
Ultrasonography-guided core-needle biopsy of parotid gland masses. AJNR Am J Neuroradiol (2004) 1.08
Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. J Cell Physiol (2003) 1.07
Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int J Surg Pathol (2004) 1.07
Identification of MYO18A as a novel interacting partner of the PAK2/betaPIX/GIT1 complex and its potential function in modulating epithelial cell migration. Mol Biol Cell (2009) 1.07
Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology. Thyroid (2005) 1.07
Value of CT in the discrimination of fatal from non-fatal stercoral colitis. Korean J Radiol (2012) 1.06
Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology. J Proteome Res (2011) 1.06
Necrotic stercoral colitis: importance of computed tomography findings. World J Gastroenterol (2011) 1.06
Congenital mixed malignant germ cell tumor involving cerebrum and orbit. J Perinat Med (2003) 1.06
Complex mutation patterns of epidermal growth factor receptor gene associated with variable responses to gefitinib treatment in patients with non-small cell lung cancer. Lung Cancer (2006) 1.05
High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol (2009) 1.05
Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys (2008) 1.05
Primary angiosarcoma of the spleen in a child with long-term survival. Pediatr Surg Int (2007) 1.05
Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer (2007) 1.04
Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma. Head Neck (2011) 1.04
Renal metastasis from papillary thyroid microcarcinoma. Acta Otolaryngol (2005) 1.04
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncol (2011) 1.03
The clinical experience of medulloblastoma treatment and the significance of time sequence for development of leptomeningeal metastasis. Childs Nerv Syst (2008) 1.02
Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas. Jpn J Clin Oncol (2006) 1.02
Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation. Int J Radiat Oncol Biol Phys (2012) 1.02
Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics. J Proteomics (2013) 1.02
Curcumin inhibits UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermoid carcinoma A431 cells. J Cell Biochem (2003) 1.02
Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression. Histol Histopathol (2008) 1.01
Primary thyroid-like papillary adenocarcinoma of the nasopharynx. Auris Nasus Larynx (2008) 1.01
Inhibition of cell migration by autophosphorylated mammalian sterile 20-like kinase 3 (MST3) involves paxillin and protein-tyrosine phosphatase-PEST. J Biol Chem (2006) 1.01
A novel role for TNFAIP2: its correlation with invasion and metastasis in nasopharyngeal carcinoma. Mod Pathol (2010) 1.01
Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes. Clin Cancer Res (2008) 1.01
Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry. FEBS J (2010) 1.00
Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. Oral Oncol (2006) 1.00
Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers. J Proteomics (2012) 0.99
Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis. Proteomics (2010) 0.99
Evaluation of the prognostic value of CD44 in glioblastoma multiforme. Anticancer Res (2010) 0.98
Lipoblastoma/lipoblastomatosis: a clinicopathologic study of 16 cases in Taiwan. Pediatr Surg Int (2005) 0.98
Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma. Head Neck (2002) 0.97
Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer (2008) 0.97
Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis. J Proteome Res (2011) 0.97
Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories. Cancer (2007) 0.97
Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. Int J Cancer (2010) 0.97
Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs. Cancer (2003) 0.97